Description
Coport M is a combination tablet that contains Empagliflozin (5 mg) and Metformin Hydrochloride (500 mg). It is used in the management of type 2 diabetes mellitus, particularly when diet, exercise, and metformin alone are not sufficient to control blood sugar levels.
-
Empagliflozin: This is an SGLT2 inhibitor that works by preventing the kidneys from reabsorbing glucose, thus increasing glucose excretion in urine and lowering blood sugar levels.
-
Metformin: It is a biguanide that works by reducing glucose production in the liver, decreasing glucose absorption in the intestines, and improving insulin sensitivity.
This combination therapy works by targeting different mechanisms of glucose regulation to effectively control blood sugar levels in patients with type 2 diabetes.
 04 Pcs.jpg)
 60Pcs.webp)
.jpg)
.webp)
 05 Pcs.jpg)
4 pcs.jpg)
32 pcs.jpg)
 50ML..webp)
.jpg)
.webp)
 48 Pcs.jpg)
 50 Pcs.jpg)
.png)
 05 Pcs.jpg)
.jpg)
 04 Pcs.png)
.jpeg)
.jpg)
.jpeg)
.jpg)
.jpg)
32 pcs.jpeg)
 300ml.jpeg)
 BELT 36PCS.jpg)
4 pcs.webp)
.webp)
 kg 24 pcs.jpg)
 24 PCS.jpg)
Change Language